To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene COMMD4TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
415 supporting clones for gene COMMD4 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB462416 testis .a 1 to 481 1 to 481   tiling clone,   481/481
(100 %)
2 diff
(99.6 %id)
DB460659 testis .a 26 to 510 1 to 485       485/485
(100 %)
1 diff
(99.8 %id)
TI_57176742   .a 99 to 791 28 to 720       693/720
(96 %)
6 diff
(99.2 %id)
BI829484 brain, medulla .a 106 to 791 1 to 686       686/686
(100 %)
0 diff
(100 %id)
BM708705 eye, RPE and Choroid .a 131 to 612 1 to 482   fully sequenced,   482/482
(100 %)
0 diff
(100 %id)
BI546726 brain, hippocampus .a 140 to 957 1 to 819       819/820
(99 %)
14 diff
(98.3 %id)
BM563267 brain, medulla .a 143 to 1067 1 to 926       926/932
(99 %)
12 diff
(98.8 %id)
NM_017828.3   .a 143 to 1065 1 to 923   RefSeq, AAA   923/923
(100 %)
0 diff
(100 %id)
TI_44168743   .a 145 to 957 92 to 905       814/906
(89 %)
14 diff
(98.5 %id)
BP368817 testis .a 145 to 770 1 to 628       628/628
(100 %)
4 diff
(99.4 %id)
BU598681 mixed (pool of 40 RNAs) .a 146 to 910 1 to 772       772/773
(99 %)
16 diff
(98.0 %id)
CD248686 embryonic stem cells, WA01, passage 38 .a 154 to 658 1 to 515       515/1179
(43 %)
33 diff
(97.3 %id)
BF214520 bone marrow, from acute myelogenous leukemia .a 154 to 740 1 to 577       577/709
(81 %)
23 diff
(96.8 %id)
BI160537 epithelioid carcinoma cell line, Pancreas .a 161 to 955 1 to 793       793/797
(99 %)
12 diff
(98.5 %id)
BF684665 leiomyosarcoma cell line, uterus .a 162 to 964 1 to 802       797/900
(88 %)
33 diff
(96.4 %id)
BF982508 duodenal adenocarcinoma, cell line, small intestine .a 162 to 932 23 to 788       766/1026
(74 %)
44 diff
(95.8 %id)
BG033064 breast, mammary adenocarcinoma, cell line .a 162 to 952 1 to 788       788/998
(78 %)
26 diff
(97.4 %id)
CB998167 placenta, pre-eclamptic placenta .a 162 to 920 17 to 779       763/779
(97 %)
12 diff
(98.5 %id)
BU146278 epidermoid carcinoma, cell line, salivary gland .a 164 to 819 1 to 658       658/897
(73 %)
13 diff
(98.6 %id)
BM770667 Ascites, stomach .a 164 to 798 1 to 635       635/635
(100 %)
1 diff
(99.9 %id)
BM835638 stomach .a 165 to 798 1 to 634       634/634
(100 %)
0 diff
(100 %id)
BM850599 stomach .a 167 to 625 1 to 459       459/459
(100 %)
1 diff
(99.8 %id)
BG396213 eye, retinoblastoma .a 168 to 978 1 to 793       793/954
(83 %)
19 diff
(98.1 %id)
BG705947 brain, hypothalamus .a 168 to 861 1 to 694       694/694
(100 %)
6 diff
(99.2 %id)
BG718738 testis .a 168 to 1012 1 to 836       836/840
(99 %)
13 diff
(98.5 %id)
H40208 brain .a 169 to 545 1 to 380       380/388
(97 %)
11 diff
(97.2 %id)
BM790550 stomach .a 169 to 758 1 to 591       591/591
(100 %)
1 diff
(99.9 %id)
BM789924 stomach .a 170 to 797 1 to 629       629/629
(100 %)
1 diff
(99.9 %id)
BM790098 stomach .a 170 to 766 1 to 597       597/597
(100 %)
0 diff
(100 %id)
BM918798 pooled pancreas and spleen .a 171 to 1063 1 to 895       895/1109
(80 %)
21 diff
(98.2 %id)
BM839841 myeloma .a 171 to 671 1 to 501       501/501
(100 %)
0 diff
(100 %id)
BM840155 myeloma .a 171 to 766 1 to 596       596/596
(100 %)
0 diff
(100 %id)
BM819628 stomach .a 171 to 663 13 to 504       492/504
(97 %)
7 diff
(98.7 %id)
CR599145 HeLa cells Cot 25-normalized .a 172 to 1067 1 to 896   tiling clone,   896/896
(100 %)
0 diff
(100 %id)
BX324652 Placenta Cot 25-normalized .a 172 to 1067 1 to 895       895/895
(100 %)
7 diff
(99.3 %id)
AL555748 placenta .a 172 to 1067 1 to 896   fully sequenced,   896/896
(100 %)
5 diff
(99.5 %id)
BP318363 pericardium .a 172 to 748 1 to 581       581/582
(99 %)
11 diff
(98.2 %id)
AK314740 Prostate .a 173 to 799 1 to 627       627/627
(100 %)
0 diff
(100 %id)
BP216895 corpus callosum .a 173 to 754 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BM761520 lymph node, stomach .a 173 to 627 1 to 455       455/455
(100 %)
1 diff
(99.8 %id)
BM840781 lymph node, stomach .a 173 to 645 1 to 473       473/473
(100 %)
0 diff
(100 %id)
BM708710 eye, RPE and Choroid .a 173 to 612 1 to 440   fully sequenced,   440/440
(100 %)
0 diff
(100 %id)
DA514285 brain .a 174 to 685 2 to 515   capped   514/514
(100 %)
2 diff
(99.7 %id)
DB458702 testis .a 174 to 619 1 to 446       446/446
(100 %)
3 diff
(99.4 %id)
DA878663 Prostate .a 174 to 739 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
BM853276 myeloma .a 174 to 671 11 to 508       498/498
(100 %)
0 diff
(100 %id)
DB009538 colon, tumor tissue .a 174 to 637 2 to 465   capped   464/464
(100 %)
0 diff
(100 %id)
BP248858 Kidney .a 176 to 757 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BM451253 eye, retinoblastoma .a 178 to 871 7 to 702       696/909
(76 %)
27 diff
(97.1 %id)
BQ433106 epithelioid carcinoma, Pancreas .a 179 to 1032 1 to 869       869/870
(99 %)
19 diff
(97.9 %id)
BU154620 melanotic melanoma, skin .a 179 to 1018 1 to 852       852/882
(96 %)
15 diff
(98.3 %id)
BM804111 eye, retinoblastoma .a 183 to 725 1 to 544       544/1116
(48 %)
7 diff
(99.4 %id)
CB994667 placenta, pre-eclamptic placenta .a 183 to 944 28 to 801       774/802
(96 %)
38 diff
(95.3 %id)
BC068998 Breast, adenocarcinoma .a 184 to 1065 1 to 882   available from MGC, AAA   882/882
(100 %)
0 diff
(100 %id)
BU180501 epidermoid carcinoma, cell line, salivary gland .a 184 to 893 26 to 737       712/935
(76 %)
30 diff
(96.8 %id)
AV727423 hypothalamus .a 185 to 604 1 to 420       420/420
(100 %)
2 diff
(99.6 %id)
BG335546 choriocarcinoma, placenta .a 185 to 920 1 to 728       728/959
(75 %)
24 diff
(97.5 %id)
BG280913 melanotic melanoma, skin .a 185 to 988 1 to 808       808/983
(82 %)
22 diff
(97.8 %id)
BG334074 melanotic melanoma, skin .a 185 to 934 1 to 745       745/782
(95 %)
10 diff
(98.8 %id)
BG419396 Kidney, renal cell adenocarcinoma .a 185 to 977 1 to 789       789/896
(88 %)
10 diff
(98.9 %id)
BG475605 melanotic melanoma, skin .a 185 to 836 1 to 650       650/652
(99 %)
11 diff
(98.4 %id)
BI160047 epithelioid carcinoma cell line, Pancreas .a 185 to 696 1 to 511       511/515
(99 %)
3 diff
(99.5 %id)
BQ638981 eye, retina .a 186 to 758 1 to 573       573/573
(100 %)
0 diff
(100 %id)
BG034268 breast, mammary adenocarcinoma, cell line .a 186 to 1011 1 to 825       825/896
(92 %)
30 diff
(96.7 %id)
BG290821 bladder, transitional cell papilloma, cell line .a 186 to 981 1 to 789       789/857
(92 %)
19 diff
(97.8 %id)
BG752433 eye, normal pigmented retinal epithelium .a 186 to 1050 1 to 865       865/865
(100 %)
18 diff
(98.0 %id)
BM020952 astrocytoma grade IV, cell line, brain .a 186 to 1066 1 to 886       886/936
(94 %)
48 diff
(94.9 %id)
BM910302 astrocytoma grade IV, cell line, brain .a 186 to 743 17 to 576       560/1212
(46 %)
25 diff
(98.0 %id)
BU558124 adenocarcinoma, cell line, breast .a 186 to 1065 1 to 886       886/958
(92 %)
33 diff
(96.6 %id)
TI_57192963   .a 186 to 1067 47 to 911       865/868
(99 %)
25 diff
(97.2 %id)
TI_59390682   .a 186 to 1066 95 to 980       888/936
(94 %)
45 diff
(95.2 %id)
BF688777 eye, normal pigmented retinal epithelium .a 187 to 531 1 to 345   fully sequenced,   345/345
(100 %)
0 diff
(100 %id)
BF662875 B-cells, primary B-cells from tonsils (cell line) .a 187 to 758 1 to 573       573/875
(65 %)
9 diff
(99.0 %id)
BF793470 adrenal cortex carcinoma, cell line, adrenal gland .a 187 to 989 1 to 793       793/851
(93 %)
16 diff
(98.2 %id)
BG750196 eye, normal pigmented retinal epithelium .a 187 to 1064 1 to 865   AAA   865/865
(100 %)
19 diff
(97.9 %id)
BI253729 cervical carcinoma cell line, cervix .a 187 to 957 1 to 770       770/770
(100 %)
23 diff
(97.1 %id)
BI862072 breast, mammary adenocarcinoma, cell line .a 187 to 1067 1 to 864       864/867
(99 %)
25 diff
(97.2 %id)
BU169252 epidermoid carcinoma, cell line, salivary gland .a 187 to 931 1 to 755       755/908
(83 %)
21 diff
(97.7 %id)
BQ962103 epithelioid carcinoma cell line, Pancreas .a 187 to 888 1 to 709       709/844
(84 %)
9 diff
(99.0 %id)
BQ428284 melanotic melanoma, skin .a 188 to 1057 1 to 875       875/890
(98 %)
22 diff
(97.6 %id)
BF304263 muscle, rhabdomyosarcoma .a 190 to 935 1 to 733       733/923
(79 %)
18 diff
(98.1 %id)
BF792117 adrenal cortex carcinoma, cell line, adrenal gland .a 190 to 849 1 to 660       660/660
(100 %)
1 diff
(99.9 %id)
BM913977 astrocytoma grade IV, cell line, brain .a 192 to 1026 1 to 849       849/1108
(76 %)
25 diff
(97.8 %id)
BU501674 brain, neuroblastoma, cell line .a 192 to 811 1 to 623       623/1072
(58 %)
8 diff
(99.3 %id)
CN255951 embryonic stem cells, DMSO-treated H9 cellline .a 194 to 910 1 to 717       717/717
(100 %)
0 diff
(100 %id)
BF685302 leiomyosarcoma cell line, uterus .a 194 to 942 1 to 743       743/906
(82 %)
34 diff
(96.3 %id)
BM710574 eye, RPE and Choroid .a 194 to 798 1 to 605       605/605
(100 %)
4 diff
(99.4 %id)
BM727747 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 194 to 455 1 to 262   fully sequenced,   262/262
(100 %)
0 diff
(100 %id)
AV698170 hepatocellular carcinoma .a 195 to 877 1 to 677       677/680
(99 %)
10 diff
(98.6 %id)
W17333 lung .a 195 to 680 1 to 481       481/481
(100 %)
9 diff
(98.2 %id)
BG758577 B-cells, primary B-cells from tonsils (cell line) .a 201 to 1046 1 to 845       845/848
(99 %)
15 diff
(98.3 %id)
CR618327 Neuroblastoma Cot 50-normalized .a 202 to 1045 1 to 844       844/844
(100 %)
0 diff
(100 %id)
AL528880 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 202 to 1032 1 to 832       832/832
(100 %)
5 diff
(99.4 %id)
TI_227712506   .a 202 to 1067 945 to 79       867/1081
(80 %)
9 diff
(99.2 %id)
TI_149288168   .a 207 to 1060 927 to 85   AAA   845/1036
(81 %)
22 diff
(97.9 %id)
TI_149297512   .a 208 to 1067 911 to 56       856/1065
(80 %)
10 diff
(99.1 %id)
TI_149288006   .a 213 to 1067 903 to 59       845/1034
(81 %)
12 diff
(98.9 %id)
BU855491 ovary, teratocarcinoma, cell line .a 218 to 1060 10 to 854   AAA   840/855
(98 %)
19 diff
(97.8 %id)
H39526 breast .a 219 to 300 1 to 82       82/82
(100 %)
0 diff
(100 %id)
AA432327   .a 257 to 678 1 to 419   fully sequenced,   419/419
(100 %)
4 diff
(99.1 %id)
TI_149287382   .a 274 to 1065 862 to 73   AAA   790/1082
(73 %)
11 diff
(99.0 %id)
CR603489 B cells (Ramos cell line) Cot 25-normalized .a 341 to 1067 1 to 727       727/727
(100 %)
0 diff
(100 %id)
AL560736 B cells from Burkitt lymphoma .a 341 to 1067 1 to 727   fully sequenced,   727/727
(100 %)
0 diff
(100 %id)
BM982563 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 345 to 1065 737 to 19   AAA   719/719
(100 %)
2 diff
(99.8 %id)
BQ671139 epidermoid carcinoma, cell line, salivary gland .a 346 to 1066 1 to 721   AAA   721/721
(100 %)
1 diff
(99.9 %id)
BQ004714 Chondrosarcoma, Left Pelvis .a 355 to 1065 729 to 19   AAA   711/711
(100 %)
0 diff
(100 %id)
CD367036 Alveolar Macrophage, lung .a 355 to 1065 729 to 19   AAA   711/711
(100 %)
0 diff
(100 %id)
BU681193 lung .a 357 to 1065 726 to 19   AAA   708/708
(100 %)
1 diff
(99.9 %id)
CB528611 Aveolar Macrophage, lung .a 357 to 1065 727 to 19   AAA   709/709
(100 %)
1 diff
(99.9 %id)
TI_149302289   .a 380 to 1065 763 to 83   AAA   681/922
(73 %)
5 diff
(99.5 %id)
TI_154102428   .a 380 to 1065 766 to 84   AAA   683/791
(86 %)
10 diff
(98.8 %id)
BM980511 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 380 to 1065 699 to 19   AAA   681/728
(93 %)
5 diff
(99.4 %id)
BQ009620 Chondrosarcoma, Left Pubic Bone .a 381 to 1065 703 to 19   AAA   685/685
(100 %)
0 diff
(100 %id)
CF530128 placenta .a 381 to 1065 702 to 19   AAA   684/684
(100 %)
1 diff
(99.9 %id)
BM041254 Kidney, Wilms' tumor, cell line .a 387 to 1057 1 to 672   fully sequenced,   672/672
(100 %)
8 diff
(98.9 %id)
BU730380 eye, RPE and Choroid .a 417 to 1065 667 to 19   AAA   649/649
(100 %)
1 diff
(99.9 %id)
BQ019986 Chondrosarcoma, Left Pubic Bone .a 419 to 1065 665 to 19   AAA   647/650
(99 %)
0 diff
(100 %id)
BM972709 lung .a 420 to 1065 664 to 19   AAA   646/646
(100 %)
3 diff
(99.6 %id)
BM681395 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 425 to 1064 653 to 15   fully sequenced, AAA   639/639
(100 %)
1 diff
(99.9 %id)
BM671882 eye, RPE and Choroid .a 426 to 1065 659 to 19   AAA   641/641
(100 %)
1 diff
(99.9 %id)
CA309263 Alveolar Macrophage, lung .a 431 to 1064 649 to 16   AAA   634/634
(100 %)
0 diff
(100 %id)
AA043677 uterus .a 441 to 789 1 to 350   fully sequenced,   350/350
(100 %)
6 diff
(98.3 %id)
AL555747 placenta .a 470 to 1020 564 to 1   fully sequenced,   577/577
(100 %)
57 diff
(90.2 %id)
BF689344 eye, normal pigmented retinal epithelium .a 470 to 989 523 to 1   fully sequenced,   523/523
(100 %)
3 diff
(99.5 %id)
BI199263 brain, neuroblastoma .a 470 to 1067 1 to 600       600/789
(76 %)
10 diff
(98.8 %id)
BI199149 brain, neuroblastoma .a 470 to 1061 1 to 590   AAA   590/590
(100 %)
6 diff
(99.0 %id)
CA445509 Chondrosarcoma, Left Pubic Bone .a 476 to 1065 607 to 19   AAA   589/589
(100 %)
2 diff
(99.7 %id)
BE313890 brain, neuroblastoma .a 490 to 1061 1 to 577       577/692
(83 %)
9 diff
(98.7 %id)
AA587100 colon, colon tumor RER+ .a 491 to 1066 576 to 1       576/598
(96 %)
11 diff
(98.2 %id)
BM970234 lung .a 494 to 1060 583 to 17   AAA   567/568
(99 %)
3 diff
(99.5 %id)
AI807021 pooled .a 511 to 1063 553 to 1       553/553
(100 %)
2 diff
(99.7 %id)
BE858465 brain, glioblastoma (pooled) .a 530 to 1060 531 to 1       531/531
(100 %)
0 diff
(100 %id)
AW069258 bone marrow stroma .a 534 to 1065 553 to 22   AAA   532/532
(100 %)
0 diff
(100 %id)
BF058545 fibrotheoma, ovary .a 537 to 1065 529 to 1       529/529
(100 %)
2 diff
(99.7 %id)
AI809996 pooled .a 543 to 1063 524 to 4       521/524
(99 %)
0 diff
(100 %id)
BF438515 brain, glioblastoma (pooled) .a 549 to 1060 512 to 1       512/512
(100 %)
0 diff
(100 %id)
AL560735 B cells from Burkitt lymphoma .a 551 to 981 477 to 48   fully sequenced,   430/477
(90 %)
2 diff
(99.6 %id)
BM041390 Kidney, Wilms' tumor, cell line .a 551 to 1020 467 to 1   fully sequenced,   465/465
(100 %)
11 diff
(97.7 %id)
BU731896 eye, RPE and Choroid .a 551 to 1065 533 to 19   fully sequenced, AAA   515/515
(100 %)
0 diff
(100 %id)
BU731903 eye, RPE and Choroid .a 551 to 1065 533 to 19   fully sequenced, AAA   515/515
(100 %)
0 diff
(100 %id)
DB303727 brain .a 562 to 1065 503 to 1       503/509
(98 %)
14 diff
(97.3 %id)
DB524201 testis .a 566 to 1065 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
AI802436   .a 575 to 1067 495 to 3       493/495
(99 %)
0 diff
(100 %id)
BE044212 pooled .a 577 to 1063 487 to 1       487/487
(100 %)
0 diff
(100 %id)
BF680365 Prostate .a 582 to 1051 1 to 468       468/526
(88 %)
3 diff
(99.5 %id)
TI_154089902   .a 582 to 1065 582 to 99   AAA   484/549
(88 %)
15 diff
(97.3 %id)
AI571381 anaplastic oligodendroglioma, brain .a 585 to 1065 480 to 1       480/480
(100 %)
1 diff
(99.8 %id)
DB527846 testis .a 599 to 1065 1 to 467     Submitted on the opposite strand 467/467
(100 %)
0 diff
(100 %id)
AI806309 pooled .a 611 to 1065 455 to 1       455/455
(100 %)
1 diff
(99.8 %id)
AW300915 colon, moderately differentiated adenocarcinoma .a 613 to 1067 455 to 1       455/455
(100 %)
0 diff
(100 %id)
AW205470   .a 614 to 1065 469 to 18   AAA   452/452
(100 %)
1 diff
(99.8 %id)
AA531134 normal prostatic epithelial cells, Prostate .a 620 to 1067 450 to 7       444/451
(98 %)
14 diff
(96.9 %id)
AA070371   .a 621 to 1066 446 to 1       446/446
(100 %)
8 diff
(98.3 %id)
AI096853 brain, glioblastoma (pooled) .a 624 to 1067 444 to 1       444/444
(100 %)
0 diff
(100 %id)
AI097474 heart .a 626 to 1066 441 to 1       441/441
(100 %)
0 diff
(100 %id)
AI818183 normal prostate, Prostate .a 627 to 1062 436 to 1       436/436
(100 %)
1 diff
(99.8 %id)
AI197995 anaplastic oligodendroglioma, brain .a 635 to 1066 434 to 1       434/434
(100 %)
6 diff
(98.7 %id)
BF436043 pooled .a 637 to 1060 424 to 1       424/424
(100 %)
0 diff
(100 %id)
AA552235 colon, tumor .a 640 to 1064 423 to 1       423/423
(100 %)
2 diff
(99.6 %id)
H40209 brain .a 645 to 1056 429 to 16       414/429
(96 %)
12 diff
(97.3 %id)
AI018444   .a 650 to 1065 425 to 13   AAA   413/413
(100 %)
3 diff
(99.3 %id)
AA429576   .a 651 to 1065 413 to 1   fully sequenced,   413/413
(100 %)
2 diff
(99.6 %id)
DB526061 testis .a 652 to 1065 1 to 414     Submitted on the opposite strand 414/414
(100 %)
1 diff
(99.8 %id)
BF195093 fibrotheoma, ovary .a 652 to 1066 414 to 1       414/414
(100 %)
7 diff
(98.4 %id)
AA648319 germinal center B cell .a 657 to 1067 411 to 3       409/411
(99 %)
2 diff
(99.6 %id)
AA887302 Kidney .a 657 to 1065 406 to 1       406/406
(100 %)
4 diff
(99.1 %id)
AA906106 pooled .a 657 to 1067 411 to 4       408/411
(99 %)
2 diff
(99.6 %id)
H96846 melanocyte .a 668 to 1065 400 to 1       400/402
(99 %)
6 diff
(98.6 %id)
AA888793 parathyroid gland, parathyroid tumor .a 668 to 1068 414 to 15   tiling clone, AAA   400/402
(99 %)
1 diff
(99.8 %id)
AI148280 senescent fibroblast .a 671 to 1067 398 to 2       397/398
(99 %)
0 diff
(100 %id)
AI445137 colon, moderately-differentiated adenocarcinoma .a 672 to 1067 398 to 3       396/398
(99 %)
0 diff
(100 %id)
H28039 breast .a 678 to 1060 386 to 2       385/390
(98 %)
3 diff
(99.3 %id)
AI204567 lung .a 678 to 1066 389 to 1       389/389
(100 %)
0 diff
(100 %id)
AI083877 anaplastic oligodendroglioma, brain .a 678 to 1063 387 to 2       386/387
(99 %)
0 diff
(100 %id)
AI239682 pooled .a 680 to 1067 389 to 2       388/389
(99 %)
1 diff
(99.8 %id)
N29476.
matches multiple genes
melanocyte .a 683 to 1065 393 to 1     also hits gene WDR41 393/433
(90 %)
10 diff
(97.7 %id)
AI149394 uterus .a 683 to 1067 387 to 3       385/387
(99 %)
0 diff
(100 %id)
AA770343   .a 684 to 1067 384 to 1       384/384
(100 %)
0 diff
(100 %id)
AW674220   .a 687 to 1065 413 to 35   AAA   379/380
(99 %)
0 diff
(100 %id)
AW470906 lung, two pooled squamous cell carcinomas .a 688 to 1065 378 to 1       378/378
(100 %)
1 diff
(99.8 %id)
BF222070 Prostate .a 688 to 1065 391 to 14   AAA   378/378
(100 %)
11 diff
(97.1 %id)
BF732744 fibrotheoma, ovary .a 689 to 1067 379 to 1       379/379
(100 %)
2 diff
(99.5 %id)
BF111404 pooled .a 689 to 1067 379 to 1       379/379
(100 %)
3 diff
(99.3 %id)
AA778929 liver and spleen .a 690 to 1060 371 to 1       371/371
(100 %)
1 diff
(99.8 %id)
AA079269   .a 690 to 1066 384 to 1       384/434
(88 %)
9 diff
(98.0 %id)
AA829475 germinal center B cell .a 695 to 1065 381 to 11   AAA   371/371
(100 %)
2 diff
(99.5 %id)
AA625976   .a 697 to 1067 373 to 4       370/373
(99 %)
0 diff
(100 %id)
AA939067 pooled .a 697 to 1067 374 to 4       371/374
(99 %)
3 diff
(99.2 %id)
AA044594 uterus .a 699 to 1067 373 to 3       371/375
(98 %)
2 diff
(99.5 %id)
AI198216 anaplastic oligodendroglioma, brain .a 703 to 1066 364 to 1       364/364
(100 %)
0 diff
(100 %id)
AA458486 ovarian tumor, ovary .a 704 to 1057 355 to 1       355/355
(100 %)
1 diff
(99.8 %id)
AW270743 brain, three pooled meningiomas .a 707 to 1067 361 to 1       361/361
(100 %)
2 diff
(99.5 %id)
AA306219   .a 708 to 1067 364 to 4     Submitted on the opposite strand 361/364
(99 %)
1 diff
(99.8 %id)
AI392613 pooled .a 710 to 1056 354 to 8       347/354
(98 %)
0 diff
(100 %id)
BG058444 head/neck, nasopharyngeal carcinoma .a 711 to 1067 46 to 401       356/405
(87 %)
9 diff
(97.8 %id)
AA429906   .a 714 to 1060 360 to 14   AAA   347/347
(100 %)
0 diff
(100 %id)
AA043678 uterus .a 728 to 1067 342 to 3   fully sequenced,   340/342
(99 %)
0 diff
(100 %id)
AI024607   .a 728 to 1065 349 to 12   AAA   338/338
(100 %)
1 diff
(99.8 %id)
EL946456 eyeball .a 729 to 1060 1 to 332   AAA   332/332
(100 %)
3 diff
(99.1 %id)
AA985602 Kidney, kidney tumor .a 735 to 1065 349 to 19   AAA   331/331
(100 %)
1 diff
(99.7 %id)
T98864 liver and spleen .a 739 to 1061 328 to 2       327/392
(83 %)
0 diff
(100 %id)
AA279418 germinal center B cell .a 756 to 1066 311 to 1       311/311
(100 %)
0 diff
(100 %id)
AI040489 liver and spleen .a 760 to 1060 300 to 1       300/300
(100 %)
1 diff
(99.7 %id)
BF345329 anaplastic oligodendroglioma with 1p/19qloss, brain .a 760 to 1065 17 to 323   AAA   307/323
(95 %)
6 diff
(98.2 %id)
BU566746 mixed (pool of 40 RNAs) .a 761 to 1061 1 to 301   AAA   301/301
(100 %)
6 diff
(98.1 %id)
AA743387 germinal center B cell .a 764 to 1060 347 to 51   AAA   297/297
(100 %)
1 diff
(99.7 %id)
AI868792 pooled .a 767 to 1065 299 to 1       299/299
(100 %)
0 diff
(100 %id)
BU752821 placenta .a 778 to 1065 305 to 18   AAA   288/288
(100 %)
0 diff
(100 %id)
AA157773   .a 789 to 1065 286 to 11   AAA   276/276
(100 %)
1 diff
(99.7 %id)
N78964 lung .a 801 to 1067 266 to 1       266/266
(100 %)
1 diff
(99.7 %id)
AA715088 germinal center B cell .a 805 to 1065 271 to 11   AAA   261/261
(100 %)
0 diff
(100 %id)
AI239993 pooled .a 821 to 1067 242 to 2       241/242
(99 %)
0 diff
(100 %id)
AI559350 anaplastic oligodendroglioma, brain .a 838 to 1060 223 to 1       223/223
(100 %)
0 diff
(100 %id)
DW424805 Liver .a 844 to 1064 17 to 237   AAA   221/237
(93 %)
6 diff
(97.5 %id)
AI201840 Prostate .a 845 to 1063 220 to 2       219/220
(99 %)
0 diff
(100 %id)
AA995602 2 pooled tumors (clear cell type), Kidney .a 848 to 1067 223 to 4       220/223
(98 %)
0 diff
(100 %id)
H96342 melanocyte .a 852 to 1043 191 to 1       191/191
(100 %)
1 diff
(99.5 %id)
BU158868 embryonal carcinoma, cell line, testis .a 866 to 1065 1 to 200   AAA   200/200
(100 %)
0 diff
(100 %id)
BG928210 cartilage .a 894 to 1065 86 to 257   AAA   172/189
(91 %)
0 diff
(100 %id)
AA609100   .a 902 to 1063 162 to 1       162/162
(100 %)
0 diff
(100 %id)
R62489 breast .a 930 to 1060 131 to 1       131/131
(100 %)
0 diff
(100 %id)
AA758998   .a 950 to 1067 119 to 2       118/119
(99 %)
0 diff
(100 %id)
AI424508 brain, glioblastoma (pooled) .a 952 to 1067 117 to 2       116/118
(98 %)
0 diff
(100 %id)
AA862721 pooled germ cell tumors .a 982 to 1060 79 to 1       79/79
(100 %)
0 diff
(100 %id)
BI855651 breast, mammary adenocarcinoma, cell line .b 1 to 666 9 to 681 S3A E4T A5L W6S E56V ... tiling clone,   673/682
(98 %)
24 diff
(96.5 %id)
TI_57186286   .b 1 to 666 66 to 738 S3A E4T A5L W6S E56V ...     673/683
(98 %)
24 diff
(96.5 %id)
AL136872 testis .c 1 to 1928 1 to 1928 exact tiling clone, available from DKFZ, AAA   1928/1928
(100 %)
0 diff
(100 %id)
AA373386 lung .c 9 to 322 1 to 320       320/324
(98 %)
14 diff
(95.7 %id)
AA380309   .c 9 to 328 1 to 321       321/321
(100 %)
6 diff
(98.2 %id)
AA353577   .c 17 to 206 17 to 206       185/207
(89 %)
10 diff
(95.2 %id)
CN255957 embryonic stem cells, cell lines H1, H7, andH9 .c 17 to 495 28 to 506       474/506
(93 %)
6 diff
(98.9 %id)
AA223847.
matches multiple genes
  .c 17 to 380 1 to 375     also hits gene TMEM14CandTMEM14BandSYCP2L 370/394
(93 %)
18 diff
(95.5 %id)
BF347821 anaplastic oligodendroglioma with 1p/19qloss, brain .c 17 to 758 1 to 723       723/951
(76 %)
12 diff
(98.8 %id)
BG290376 bladder, transitional cell papilloma, cell line .c 17 to 761 1 to 751       751/826
(90 %)
13 diff
(98.5 %id)
BG472660 eye, retinoblastoma .c 17 to 820 1 to 794       794/794
(100 %)
17 diff
(97.9 %id)
BQ069381 brain, neuroblastoma, cell line .c 17 to 848 42 to 886       845/1135
(74 %)
36 diff
(96.9 %id)
EG328646 pooled .c 18 to 207 188 to 1     Submitted on the opposite strand 188/188
(100 %)
0 diff
(100 %id)
BE547422 cervical carcinoma cell line, cervix .c 18 to 653 1 to 634       634/635
(99 %)
13 diff
(98.0 %id)
BE385987 melanotic melanoma, skin .c 18 to 642 1 to 620       620/620
(100 %)
5 diff
(99.2 %id)
BE961015 melanotic melanoma, high MDR, skin .c 18 to 734 1 to 697       637/734
(86 %)
34 diff
(95.4 %id)
BF686242 leiomyosarcoma cell line, uterus .c 18 to 614 1 to 595       595/595
(100 %)
2 diff
(99.7 %id)
BF794204 lymph, lymphoma, cell line .c 18 to 799 1 to 773       773/944
(81 %)
16 diff
(98.4 %id)
BM914018 astrocytoma grade IV, cell line, brain .c 19 to 336 33 to 355       318/1336
(23 %)
5 diff
(99.7 %id)
BE255802 eye, retinoblastoma .c 20 to 701 1 to 674       674/698
(96 %)
15 diff
(97.9 %id)
BE899461 adenocarcinoma cell line, ovary .c 20 to 724 1 to 693       693/873
(79 %)
16 diff
(98.2 %id)
BE905173 epithelioid carcinoma, Pancreas .c 22 to 782 1 to 749       749/865
(86 %)
28 diff
(96.8 %id)
BE261940 brain, neuroblastoma .c 24 to 730 1 to 732       728/812
(89 %)
56 diff
(93.2 %id)
BM817514 Ascites, stomach .c 24 to 323 1 to 300       300/300
(100 %)
0 diff
(100 %id)
BE260577 brain, neuroblastoma .c 25 to 775 1 to 742       742/892
(83 %)
15 diff
(98.4 %id)
BE731554 choriocarcinoma, placenta .c 25 to 802 1 to 767       767/859
(89 %)
12 diff
(98.7 %id)
BE902903 choriocarcinoma, placenta .c 25 to 804 1 to 767       767/814
(94 %)
17 diff
(98.0 %id)
BM551008 amelanotic melanoma, cell line, skin .c 25 to 421 1 to 397       397/1135
(34 %)
3 diff
(99.8 %id)
CN255952 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 27 to 761 1 to 735       735/735
(100 %)
0 diff
(100 %id)
BG684249 B-cells, primary B-cells from tonsils (cell line) .c 28 to 821 1 to 795       795/798
(99 %)
10 diff
(98.8 %id)
BQ330770 lung_tumor .c 31 to 400 13 to 382       365/390
(93 %)
9 diff
(97.7 %id)
BE896302 melanotic melanoma, skin .c 31 to 752 1 to 708       708/942
(75 %)
35 diff
(96.3 %id)
T99458.
matches multiple genes
liver and spleen .c 33 to 333 1 to 303     also hits gene ATXN7L1 303/351
(86 %)
8 diff
(97.8 %id)
BE263063 brain, neuroblastoma .c 33 to 509 1 to 476       476/476
(100 %)
3 diff
(99.4 %id)
BE792599 lung, small cell carcinoma .c 33 to 677 1 to 643       643/643
(100 %)
3 diff
(99.6 %id)
N42335.
matches multiple genes
melanocyte .c 37 to 535 1 to 503     also hits gene WDR41 501/503
(99 %)
13 diff
(97.5 %id)
BG762392 melanotic melanoma, high MDR (cell line), skin .c 43 to 805 1 to 781       713/905
(78 %)
21 diff
(97.7 %id)
BU535623 adenocarcinoma, cell line, breast .c 52 to 566 1 to 516       516/1050
(49 %)
20 diff
(98.1 %id)
BG768728 melanotic melanoma, high MDR (cell line), skin .c 54 to 868 1 to 815       813/846
(96 %)
21 diff
(97.6 %id)
BI857922 breast, mammary adenocarcinoma, cell line .c 55 to 570 1 to 516       516/516
(100 %)
0 diff
(100 %id)
TI_57191111   .c 55 to 570 91 to 606       516/516
(100 %)
0 diff
(100 %id)
BE827667 lung_tumor .c 56 to 265 20 to 226       208/226
(92 %)
12 diff
(94.7 %id)
BE170826 head_neck .c 58 to 235 180 to 3     Submitted on the opposite strand 178/180
(98 %)
1 diff
(99.5 %id)
AA382539 testis .c 72 to 376 1 to 305       305/305
(100 %)
4 diff
(98.7 %id)
BI334140 cervical carcinoma cell line, cervix .c 72 to 805 1 to 730       730/730
(100 %)
6 diff
(99.2 %id)
AA359263 lung .c 81 to 292 1 to 215       215/215
(100 %)
6 diff
(97.3 %id)
BE281079 choriocarcinoma, placenta .c 89 to 747 27 to 681       655/685
(95 %)
11 diff
(98.4 %id)
BP209593 cerebellum .c 99 to 678 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BM912045 amelanotic melanoma, cell line, skin .c 146 to 629 1 to 486       486/1402
(34 %)
10 diff
(99.3 %id)
BM807864 amelanotic melanoma, cell line, skin .c 156 to 880 11 to 741       731/1021
(71 %)
36 diff
(96.5 %id)
AA309653   .c 182 to 406 1 to 225       225/225
(100 %)
0 diff
(100 %id)
BQ373262 prostate_tumor .c 195 to 429 261 to 22       240/264
(90 %)
15 diff
(94.4 %id)
TI_151766639   .c 230 to 706 101 to 569       469/847
(55 %)
14 diff
(98.4 %id)
AA554853 normal prostatic epithelial cells, Prostate .c 234 to 628 8 to 403       396/403
(98 %)
2 diff
(99.6 %id)
BE940627 uterus_tumor .c 310 to 509 5 to 203       199/203
(98 %)
8 diff
(96.1 %id)
T30508 colon, endothelial .c 469 to 763 1 to 295       295/295
(100 %)
0 diff
(100 %id)
BF809076 colon_ins .c 482 to 658 25 to 201       177/201
(88 %)
7 diff
(96.6 %id)
BE934544 head_neck .c 489 to 639 157 to 5       153/157
(97 %)
3 diff
(98.1 %id)
Z19228 leg muscle, skeletal muscle .c 503 to 819 1 to 317       317/338
(93 %)
4 diff
(98.9 %id)
BF917385 uterus_tumor .c 558 to 828 1 to 271       271/271
(100 %)
0 diff
(100 %id)
BI059419 uterus_tumor .c 558 to 828 1 to 271       271/271
(100 %)
0 diff
(100 %id)
EC575258 Prostate .c 574 to 669 1 to 95       95/95
(100 %)
1 diff
(99.0 %id)
EC443144 Prostate .c 654 to 751 1 to 98       98/98
(100 %)
0 diff
(100 %id)
CD238174 Pituitary .c 852 to 1545 1 to 695       695/695
(100 %)
8 diff
(98.9 %id)
BQ347752 head_neck .c 1162 to 1582 1 to 424       424/424
(100 %)
4 diff
(99.1 %id)
DB520169 testis .c 1626 to 2069 1 to 445   tiling clone, Submitted on the opposite strand 445/446
(99 %)
2 diff
(99.6 %id)
BQ028965 Bone, Subchondral Bone .c 1669 to 1924 274 to 19   AAA   256/256
(100 %)
1 diff
(99.7 %id)
CD515440 White Matter .d 1 to 761 1 to 767 exact tiling clone,   767/811
(94 %)
6 diff
(99.3 %id)
BF213536 bone marrow, from acute myelogenous leukemia .e 1 to 704 3 to 699 F38L E39S S40Q G41A D42M ...     701/901
(77 %)
39 diff
(95.7 %id)
AA380173 skin .e 1 to 320 2 to 321       321/321
(100 %)
3 diff
(99.1 %id)
BM828442 stomach .e 1 to 638 2 to 639 exact tiling clone,   639/639
(100 %)
0 diff
(100 %id)
BG769954 melanotic melanoma, high MDR (cell line), skin .e 20 to 681 1 to 662 T171N tiling clone,   662/662
(100 %)
2 diff
(99.7 %id)
BG468836 adenocarcinoma cell line, colon .e 22 to 752 1 to 734 L137P E138G V139G A140G A141S ... tiling clone,   734/737
(99 %)
14 diff
(98.2 %id)
BQ437229 eye, retinoblastoma .e 29 to 394 1 to 369       369/843
(43 %)
8 diff
(99.1 %id)
BI771268 pooled lung and spleen .f 1 to 867 1 to 859 G16E tiling clone,   859/863
(99 %)
12 diff
(98.7 %id)
TI_57179103   .f 1 to 867 32 to 890 G16E     859/894
(96 %)
17 diff
(98.1 %id)
CB123816 Liver .g 1 to 420 3 to 422       422/422
(100 %)
3 diff
(99.3 %id)
AW954210   .g 1 to 694 17 to 708 Q161H     688/709
(97 %)
19 diff
(97.4 %id)
AV727898 hypothalamus .g 1 to 561 49 to 603   tiling clone,   556/747
(74 %)
14 diff
(98.2 %id)
BE797857 lung, small cell carcinoma .g 1 to 809 36 to 821 L165* tiling clone,   782/956
(81 %)
31 diff
(96.8 %id)
DN989503 brain, whole brain .g 1 to 687 39 to 720 G170X tiling clone,   683/721
(94 %)
11 diff
(98.5 %id)
BM044884 carcinoma, cell line, Prostate .g 1 to 429 1 to 429       429/1098
(39 %)
4 diff
(99.7 %id)
CR533452   .g 3 to 654 1 to 652 exact tiling clone,   652/652
(100 %)
2 diff
(99.7 %id)
AY542160   .g 3 to 602 1 to 600 exact     600/600
(100 %)
2 diff
(99.7 %id)
BG030636 breast, mammary adenocarcinoma, cell line .g 3 to 678 1 to 674 T138P P139Q A140P Q141S P142L ... tiling clone,   674/674
(100 %)
8 diff
(98.9 %id)
BI825827 brain, medulla .h 1 to 587 2 to 587   tiling clone,   587/587
(100 %)
1 diff
(99.9 %id)
CR985404 T-Lymphocytes .h 1 to 436 2 to 437   tiling clone,   437/437
(100 %)
2 diff
(99.6 %id)
TI_57173892   .h 8 to 587 75 to 653       579/653
(88 %)
6 diff
(99.1 %id)
TI_57219427   .h 125 to 856 63 to 799 G16A I17D D18*     737/926
(79 %)
25 diff
(97.4 %id)
BI757720 brain .h 130 to 856 1 to 732 G16A I17D D18* tiling clone,   732/859
(85 %)
20 diff
(97.7 %id)
CN263931 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .i 1 to 480 11 to 490 D2V G3R tiling clone,   480/490
(97 %)
6 diff
(98.8 %id)
BQ233598 melanotic melanoma, skin .j 1 to 746 1 to 749 G146X tiling clone, AAA   749/749
(100 %)
6 diff
(99.2 %id)
BQ218757 melanotic melanoma, skin .j 19 to 737 19 to 751 K72N tiling clone,   733/906
(80 %)
34 diff
(96.3 %id)
AK124968 thalamus .k-u 1 to 4203 2 to 4205 exact tiling clone, available from FLJ,   4205/4205
(100 %)
6 diff
(99.9 %id)
DA374009 thalamus .k-u 1 to 571 2 to 575   capped   574/574
(100 %)
4 diff
(99.4 %id)
DB182768 liver, tumor tissue .k-u 22 to 578 2 to 559   tiling clone, capped   558/560
(99 %)
3 diff
(99.5 %id)
BE161036 head_neck .k-u 71 to 507 1 to 438       438/438
(100 %)
11 diff
(97.5 %id)
BG674110 skin .k-u 3591 to 4442 1 to 855   tiling clone,   855/856
(99 %)
16 diff
(98.2 %id)
DB311047 thalamus .k-u 3698 to 4203 507 to 1       507/508
(99 %)
1 diff
(99.9 %id)
AW027633 thymus, pooled .k-u 3725 to 4209 485 to 1       485/485
(100 %)
0 diff
(100 %id)
AW008172 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .k-u 3729 to 4210 482 to 4       479/482
(99 %)
0 diff
(100 %id)
DB524057 testis .k-u 3739 to 4206 1 to 470     Submitted on the opposite strand 470/472
(99 %)
9 diff
(98.1 %id)
AW080287 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .k-u 3774 to 4210 437 to 1       437/437
(100 %)
1 diff
(99.8 %id)
AA579535   .k-u 3940 to 4213 288 to 14       275/288
(95 %)
0 diff
(100 %id)
CD370299 Alveolar Macrophage, lung .l 1 to 725 747 to 11 R2E V15S L16W A17Q E18K ... AAA   729/729
(100 %)
4 diff
(99.5 %id)
AK000459   .l 6 to 725 1 to 720 exact tiling clone, available from FLJ, AAA   720/720
(100 %)
0 diff
(100 %id)
DB059431 testis .l 11 to 552 2 to 543 E18D capped   542/542
(100 %)
1 diff
(99.9 %id)
BG420675 Kidney, renal cell adenocarcinoma .l 24 to 722 1 to 692 exact     692/824
(83 %)
8 diff
(99.1 %id)
BF568289 epithelioid carcinoma cell line, Pancreas .l 30 to 727 1 to 697 exact fully sequenced,   697/697
(100 %)
8 diff
(98.9 %id)
BF568372 epithelioid carcinoma cell line, Pancreas .l 30 to 724 1 to 688 S105A L106C C107A R108A C109V ... fully sequenced, AAA   688/688
(100 %)
12 diff
(98.3 %id)
BC000837 Cervix, carcinoma .l 40 to 725 1 to 686   available from MGC, AAA   686/686
(100 %)
0 diff
(100 %id)
CK902253 Pancreas, Purified pancreatic islet .l 62 to 607 1 to 545     Submitted on the opposite strand 545/545
(100 %)
1 diff
(99.9 %id)
BQ777827 Pancreas, Purified pancreatic islet .l 90 to 597 1 to 508       508/508
(100 %)
0 diff
(100 %id)
BF569314 epithelioid carcinoma cell line, Pancreas .l 187 to 672 483 to 1   fully sequenced,   483/483
(100 %)
8 diff
(98.4 %id)
BF569147 epithelioid carcinoma cell line, Pancreas .l 187 to 676 489 to 4   fully sequenced,   485/488
(99 %)
0 diff
(100 %id)
AI217934   .l 277 to 727 455 to 5       451/455
(99 %)
0 diff
(100 %id)
BQ777535 Pancreas, Purified pancreatic islet .l 278 to 723 447 to 1       447/447
(100 %)
5 diff
(98.9 %id)
AW117823 esophagus, squamous cell carcinoma .l 314 to 731 416 to 1       416/416
(100 %)
12 diff
(97.2 %id)
AI299521 carcinoid, lung .l 320 to 725 406 to 1       406/406
(100 %)
0 diff
(100 %id)
BE940646 uterus_tumor .l 331 to 532 207 to 5       203/211
(96 %)
9 diff
(95.8 %id)
BE940668 uterus_tumor .l 336 to 533 24 to 220       197/220
(89 %)
7 diff
(96.9 %id)
AA805702 germinal center B cell .l 346 to 725 392 to 13   AAA   380/380
(100 %)
1 diff
(99.8 %id)
AA643651 colon, colon tumor RER+ .l 348 to 720 373 to 1       373/373
(100 %)
1 diff
(99.8 %id)
AI216862   .l 361 to 727 372 to 4       369/372
(99 %)
1 diff
(99.8 %id)
DB475430 hippocampus .m 1 to 461 1 to 461 E136Q tiling clone,   461/462
(99 %)
2 diff
(99.6 %id)
TI_57176184   .n -10 to 667 54 to 730 exact     677/858
(78 %)
13 diff
(98.5 %id)
BI829264 brain, medulla .n 1 to 667 3 to 668 exact tiling clone,   668/796
(83 %)
8 diff
(99.0 %id)
AW803863 uterus .n 32 to 207 176 to 1       176/177
(99 %)
2 diff
(98.9 %id)
BQ377081 uterus .n 32 to 207 177 to 1       177/178
(99 %)
7 diff
(96.1 %id)
H46085 brain .n 38 to 368 1 to 336       336/404
(83 %)
13 diff
(96.8 %id)
CN255956 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 45 to 277 1 to 233       233/233
(100 %)
3 diff
(98.8 %id)
AA295989 thymus .n 54 to 308 1 to 255       255/255
(100 %)
5 diff
(98.1 %id)
CN255954 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 55 to 653 1 to 600       600/600
(100 %)
2 diff
(99.7 %id)
BM714514 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .n 63 to 676 1 to 614   tiling clone, fully sequenced, AAA   614/614
(100 %)
0 diff
(100 %id)
AA844360 parathyroid gland, parathyroid tumor .n 258 to 659 184 to 1       166/184
(90 %)
10 diff
(94.6 %id)
H46015 brain .n 350 to 652 304 to 1       304/311
(97 %)
9 diff
(97.2 %id)
BU739483 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .n 508 to 676 187 to 19   fully sequenced, AAA   169/169
(100 %)
0 diff
(100 %id)
EL953243 eyeball .o 1 to 567 1 to 569 E60G tiling clone,   565/569
(99 %)
5 diff
(99.2 %id)
AK293708 cerebellum .p 1 to 922 5 to 926 exact tiling clone,   926/926
(100 %)
1 diff
(99.9 %id)
DC306180 cerebellum .p 1 to 353 5 to 360       360/360
(100 %)
4 diff
(98.9 %id)
DB108589 thymus .q 1 to 587 2 to 588 K39R tiling clone, capped   587/587
(100 %)
2 diff
(99.7 %id)
BX355379 Neuroblastoma Cot 50-normalized .r 1 to 1047 1 to 1034 exact tiling clone,   1034/1065
(97 %)
23 diff
(97.9 %id)
BX351306 Neuroblastoma Cot 50-normalized .r 1814 to 2255 448 to 8   tiling clone,   441/488
(90 %)
13 diff
(97.4 %id)
BC069195 Placenta, choriocarcinoma .s 1 to 654 1 to 653 Y48M E49R K50R I51S L52* tiling clone, available from MGC, AAA   653/653
(100 %)
1 diff
(99.9 %id)
BE543553 cervical carcinoma cell line, cervix .t 1 to 692 2 to 685 S76A L77C C78A R79A C80V ... tiling clone, available from MGC,   685/852
(80 %)
14 diff
(98.4 %id)
BU540913 epithelioid carcinoma cell line, Pancreas .u 1 to 850 1 to 853 exact tiling clone,   853/861
(99 %)
7 diff
(99.2 %id)
CN255953 embryonic stem cells, DMSO-treated H9 cellline .u 21 to 543 1 to 524 exact tiling clone,   524/530
(98 %)
2 diff
(99.7 %id)
BE786963 large cell carcinoma, lung .u 120 to 717 1 to 586       586/849
(69 %)
16 diff
(98.2 %id)
TI_57215634   .va 1 to 715 33 to 746 exact tiling clone,   714/822
(86 %)
10 diff
(98.8 %id)
BC033744 Brain, adult, 6 pooled whole brains .va 2 to 2259 1 to 2258 exact tiling clone, available from MGC, AAA   2258/2258
(100 %)
1 diff
(100.0 %id)
BI753942 brain .va 2 to 715 1 to 713 exact available from MGC,   713/789
(90 %)
4 diff
(99.5 %id)
DA558455   .va 11 to 370 2 to 361 R2S capped   360/360
(100 %)
2 diff
(99.5 %id)
DA825116 pericardium .va 14 to 370 2 to 358 Q79L capped   357/357
(100 %)
1 diff
(99.8 %id)
AK057145 Spleen .va 20 to 2259 1 to 2239 I43L V44W G45V V46* available from FLJ,   2239/2239
(100 %)
2 diff
(100.0 %id)
DA532833 brain .va 20 to 424 2 to 406 G82X capped   405/405
(100 %)
0 diff
(100 %id)
DA157401 amygdala .va 21 to 562 2 to 543 exact capped   542/542
(100 %)
0 diff
(100 %id)
DA208142 brain .va 21 to 424 2 to 405 exact capped   404/404
(100 %)
1 diff
(99.8 %id)
DA259461 caudate nucleus .va 21 to 312 2 to 293   capped   292/292
(100 %)
0 diff
(100 %id)
DA583283 lung .va 21 to 394 2 to 375 exact capped   374/374
(100 %)
1 diff
(99.8 %id)
DA931479 Spleen .va 21 to 289 2 to 269   capped   268/268
(100 %)
1 diff
(99.7 %id)
BM782873 myeloma .va 27 to 195 1 to 169       169/169
(100 %)
0 diff
(100 %id)
AL554260 placenta, Placenta Cot 25-normalized .va 50 to 1004 1 to 944       944/953
(99 %)
21 diff
(97.8 %id)
TI_57183117   .va 51 to 789 59 to 806       748/847
(88 %)
19 diff
(97.8 %id)
BI771572 pooled lung and spleen .va 56 to 789 1 to 743       743/784
(94 %)
16 diff
(98.0 %id)
BE622129 melanotic melanoma, skin .va 184 to 559 1 to 389       389/495
(78 %)
14 diff
(97.2 %id)
CX782490 human embryonic stem cells .va 288 to 1087 1 to 800       800/800
(100 %)
1 diff
(99.9 %id)
BF342320 brain, glioblastoma with EGFR amplification .va 1018 to 1792 1 to 767       767/870
(88 %)
25 diff
(97.2 %id)
AL554226 placenta, Placenta Cot 25-normalized .va 1244 to 2217 973 to 10       964/1001
(96 %)
0 diff
(100 %id)
BE622954 melanotic melanoma, skin .va 1371 to 2216 877 to 25       853/952
(89 %)
41 diff
(95.7 %id)
FN131817 breast carcinoma .va 1546 to 1640 93 to 1     Submitted on the opposite strand 93/93
(100 %)
2 diff
(97.9 %id)
BQ016373 lung, Metastatic Chondrosarcoma .va 1659 to 2259 618 to 19   AAA   600/600
(100 %)
2 diff
(99.7 %id)
DB332500 Spleen .va 1737 to 2259 523 to 1       523/524
(99 %)
0 diff
(100 %id)
DW449041 Liver .va 1800 to 1993 12 to 205       194/205
(94 %)
8 diff
(96.1 %id)
DW465689 Liver .va 1800 to 2144 12 to 356       345/356
(96 %)
6 diff
(98.4 %id)
CX782409 human embryonic stem cells .va 1923 to 2255 374 to 42   AAA   333/333
(100 %)
31 diff
(90.7 %id)
DA652471   .vb 1 to 489 2 to 490   tiling clone, capped   489/489
(100 %)
2 diff
(99.6 %id)
TI_57231413   .vb 12 to 782 34 to 811   AAA   778/1059
(73 %)
33 diff
(96.9 %id)
BI906004 leukocyte .vb 13 to 782 1 to 777   available from MGC,   777/1044
(74 %)
27 diff
(97.5 %id)
BC040944 Blood, adult leukocytes .vb 30 to 1905 1 to 1876 exact tiling clone, available from MGC, AAA   1876/1876
(100 %)
1 diff
(100.0 %id)
TI_149287545   .vb 1007 to 1928 974 to 79 G3C G4C L5N H6P P7W ... AAA   896/1093
(81 %)
64 diff
(94.2 %id)
AA293523 ovarian tumor, ovary .vb 1038 to 1484 1 to 443       443/443
(100 %)
6 diff
(98.7 %id)
AA446060   .vb 1141 to 1675 1 to 534       534/534
(100 %)
5 diff
(99.1 %id)
TI_154041271   .vb 1176 to 1928 844 to 103 exact AAA   742/898
(82 %)
19 diff
(97.9 %id)
BF893849 marrow .vb 1186 to 1712 546 to 10     Submitted on the opposite strand 537/546
(98 %)
17 diff
(96.9 %id)
BM972849 lung .vb 1193 to 1928 750 to 19 exact AAA   732/732
(100 %)
5 diff
(99.4 %id)
CA449934 Chondrosarcoma, Left Pelvis .vb 1414 to 1928 533 to 19 exact AAA   515/515
(100 %)
0 diff
(100 %id)
AA293524 ovarian tumor, ovary .vb 1597 to 1928 332 to 1       332/332
(100 %)
0 diff
(100 %id)
DB454761 testis .vc 1 to 475 2 to 476       476/476
(100 %)
1 diff
(99.8 %id)
DA269084 caudate nucleus .vc 1 to 270 2 to 271   tiling clone, capped   270/270
(100 %)
1 diff
(99.7 %id)
DB037209 testis .vc 15 to 392 2 to 379   capped   378/378
(100 %)
0 diff
(100 %id)
DA961993 Spleen .vc 33 to 500 2 to 469   capped   468/468
(100 %)
1 diff
(99.8 %id)
DA010155 adrenal gland .vc 34 to 552 2 to 520   capped   519/519
(100 %)
0 diff
(100 %id)
CR618150 T cells (Jurkat cell line) Cot10-normalized .vc 71 to 1741 1 to 1671 exact tiling clone,   1671/1671
(100 %)
0 diff
(100 %id)
AL558363 T cells from T cell leukemia .vc 71 to 908 1 to 834   fully sequenced,   834/834
(100 %)
0 diff
(100 %id)
AL580203 T cells from T cell leukemia .vc 878 to 1741 860 to 1   fully sequenced,   860/860
(100 %)
13 diff
(98.5 %id)
DA605262   .vd 1 to 535 2 to 537   tiling clone, capped   536/536
(100 %)
1 diff
(99.9 %id)
BF983636 duodenal adenocarcinoma, cell line, small intestine .vd 32 to 740 1 to 709       709/924
(76 %)
20 diff
(97.9 %id)
BF916246 uterus_tumor .vd 468 to 815 349 to 1   tiling clone, Submitted on the opposite strand 349/351
(99 %)
7 diff
(98.1 %id)
BE940613 uterus_tumor .vd 486 to 864 27 to 403 exact tiling clone,   377/403
(93 %)
8 diff
(98.1 %id)
BE278037 choriocarcinoma, placenta .ve 1 to 626 2 to 626 exact tiling clone, available from MGC,   626/627
(99 %)
4 diff
(99.4 %id)
DA738883   .vf 1 to 541 4 to 544 exact tiling clone, capped   543/543
(100 %)
0 diff
(100 %id)
AA339123 brain .vg -8 to 247 1 to 255 exact     255/256
(99 %)
4 diff
(98.5 %id)
AW966283   .vg 1 to 466 6 to 472 exact tiling clone,   472/514
(91 %)
11 diff
(97.9 %id)
AK225716 testis Gene COMMD4, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BE934551 head_neck Gene COMMD4, variant not shown         Suspected internal deletion, this clone was ignored    
BG315339   Gene COMMD4, variant not shown         Suspected internal deletion, this clone was ignored    
CN255955 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 Gene COMMD4, variant not shown         Suspected internal deletion, this clone was ignored    
H54431 liver and spleen Gene COMMD4, variant not shown         Suspected internal deletion, this clone was ignored    
H54520 liver and spleen Gene COMMD4, variant not shown         Suspected internal deletion, this clone was ignored    
N29385 placenta Gene COMMD4, variant not shown         Suspected internal deletion, this clone was ignored    
N47934 placenta Gene COMMD4, variant not shown         Suspected internal deletion, this clone was ignored    
AA447085   Gene COMMD4, variant not shown         Suspected internal deletion, this clone was ignored    
BM555039 duodenal adenocarcinoma, cell line, small intestine Gene COMMD4, variant not shown         Suspected internal deletion, this clone was ignored    
TI_158436165   Gene COMMD4, variant not shown       AAA Suspected internal deletion, this clone was ignored    
CD370816 Alveolar Macrophage, lung Gene COMMD4, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI